聚丙烯中段尿道吊带术后的癌症风险
瑞典全国队列研究纳入5,385,186名女性(暴露组20,905例),总随访44,012,936人年,评估聚丙烯中段尿道吊带术与癌症风险关联。除直肠癌呈负相关(HR 0.5,95%CI 0.3-0.8)外,暴露与未暴露女性在盆腔器官癌症及其他任何器官系统原发癌风险上均无显著差异。作者认为中段尿道聚丙烯吊带术与日后癌症风险升高无关。
要点
- 暴露组与未暴露组直肠癌风险呈负相关(HR 0.5,95%CI 0.3-0.8)。
- 卵巢、子宫内膜、宫颈、膀胱及尿道癌风险在两组间均无显著差异。
- 术后4年内整体癌症风险呈负相关(HR 0.7,95%CI 0.7-0.8)。
核心结论
- 作者认为中段尿道聚丙烯吊带术治疗压力性尿失禁与日后癌症风险升高无关。
研究设计与样本
- 基于瑞典普通女性人群的全国队列研究,观察期1997年1月1日至2009年12月31日。
- 最终研究人群5,385,186名女性,其中暴露组20,905例,总风险人年44,012,936。
- 暴露定义为因压力性尿失禁行中段尿道吊带术,结局为癌症登记处确认的原发癌。
- 采用Cox比例风险回归计算风险比(HR)及95%CI。
主要发现
- 暴露组 vs 未暴露组直肠癌发病率分别为每10万人年20.5(95%CI 14.3-29.5) vs 21.0(95%CI 20.6-21.5),HR 0.5(95%CI 0.3-0.8)。
- 暴露组 vs 未暴露组卵巢癌发病率分别为每10万人年25.5(95%CI 18.4-35.3) vs 19.8(95%CI 19.4-20.2),HR 0.8(95%CI 0.5-1.2)。
- 暴露组 vs 未暴露组子宫内膜癌发病率分别为每10万人年65.0(95%CI 53.0-79.8) vs 33.1(95%CI 32.6-33.7),HR 1.1(95%CI 0.8-1.4)。
- 暴露组 vs 未暴露组宫颈癌发病率分别为每10万人年5.7(95%CI 2.8-11.3) vs 11.9(95%CI 11.6-12.2),HR 0.4(95%CI 0.2-1.0)。
- 暴露组 vs 未暴露组膀胱及尿道癌发病率分别为每10万人年19.1(95%CI 13.1-27.8) vs 13.3(95%CI 13.0-13.7),HR 0.7(95%CI 0.4-1.2)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether there is any association between the implantation of synthetic polypropylene mesh slings for the treatment of stress urinary incontinence (SUI) and risk of cancer. METHODS: We performed a nationwide cohort study based on the general female population in Sweden. All women entered the observational period as unexposed on January 1, 1997, and contributed person-time as unexposed unless they underwent a midurethral sling procedure for SUI, after which they contributed person-time as exposed until first occurrence of any cancer, death, emigration, or end of the observational period (December 31, 2009). Occurrence of primary cancer was ascertained from the Cancer Register. Hazard ratios (HRs) with 95% CIs were calculated by Cox proportional hazards regression. RESULTS: The final study population included 5,385,186 women, including 20,905 exposed, encompassing a total of 44,012,936 person-years at risk. Other than an inverse association with rectal cancer (HR 0.5, 95% CI 0.3-0.8), there were no significant differences in risk between exposed and unexposed women for pelvic organ cancers including ovarian (HR 0.8, 95% CI 0.5-1.2), endometrial (HR 1.1, 95% CI 0.8-1.4), cervical (HR 0.4, 95% CI 0.2-1.0), bladder, and urethra (HR 0.7, 95% CI 0.4-1.2). No significant association was observed between exposed women and primary cancer in any organ system when compared with unexposed women. The relative risk for cancer after exposure showed little variation over time except for an inverse overall correlation within the first 4 years of surgery (HR 0.7, 95% CI 0.7-0.8). The incidence rates per 100,000 person-years (95% CIs) for exposed vs unexposed women were 20.5 (14.3-29.5) vs 21.0 (20.6-21.5) for rectal cancer, 25.5 (18.4-35.3) vs 19.8 (19.4-20.2) for ovarian cancer, 65.0 (53.0-79.8) vs 33.1 (32.6-33.7) for endometrial cancer, 5.7 (2.8-11.3) vs 11.9 (11.6-12.2) for cervical cancer, and 19.1 (13.1-27.8) vs 13.3 (13.0-13.7) for bladder and urethra cancer. CONCLUSION: Our results suggest that midurethral polypropylene sling surgery for SUI is not associated with an increased cancer risk later in life.
引用
- Altman D, Rogers RG, Yin L, et al. Cancer Risk After Midurethral Sling Surgery Using Polypropylene Mesh. Obstet Gynecol. 2018. PMID: 29420401. doi:10.1097/AOG.0000000000002496
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。